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Abstract
Vpr, an accessory protein of human immunodeficiency virus type 1, is a multifunctional protein that plays an important role
in viral replication. We have previously shown that the region between residues 17 and 74 of Vpr (VprN17C74) contained a
bona fide nuclear localization signal and it is targeted VprN17C74 to the nuclear envelope and then imported into the nucleus
by importin a (Impa) alone. The interaction between Impa and Vpr is important not only for the nuclear import of Vpr but
also for HIV-1 replication in macrophages; however, it was unclear whether full-length Vpr enters the nucleus in a manner
similar to VprN17C74. This study investigated the nuclear import of full-length Vpr using the three typical Impa isoforms,
Rch1, Qip1 and NPI-1, and revealed that full-length Vpr is selectively imported by NPI-1, but not Rch1 and Qip1, after it
makes contact with the perinuclear region in digitonin-permeabilized cells. A binding assay using the three Impa isoforms
showed that Vpr bound preferentially to the ninth armadillo repeat (ARM) region (which is also essential for the binding of
CAS, the export receptor for Impa) in all three isoforms. Comparison of biochemical binding affinities between Vpr and the
Impa isoforms using surface plasmon resonance analysis demonstrated almost identical values for the binding of Vpr to the
full-length isoforms and to their C-terminal domains. By contrast, the data showed that, in the presence of CAS, Vpr was
released from the Vpr/NPI-1 complex but was not released from Rch1 or Qip1. Finally, the NPI-1–mediated nuclear import of
Vpr was greatly reduced in semi-intact CAS knocked-down cells and was recovered by the addition of exogenous CAS. This
report is the first to show the requirement for and the regulation of CAS in the functioning of the Vpr-Impa complex.
Citation: Takeda E, Murakami T, Matsuda G, Murakami H, Zako T, et al. (2011) Nuclear Exportin Receptor CAS Regulates the NPI-1–Mediated Nuclear Import of
HIV-1 Vpr. PLoS ONE 6(11): e27815. doi:10.1371/journal.pone.0027815
Editor: Roberto F. Speck, University Hospital Zurich, Switzerland
Received January 27, 2011; Accepted October 26, 2011; Published November 16, 2011
Copyright:  2011 Takeda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS: http://
www.jhsf.or.jp/English/index_e.html) and by the program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical
Innovation (NIBIO) of Japan (ID 06-01: http://www.nibio.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript. No additional external funding received for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: aida@riken.jp
Introduction
Molecular trafficking between the nucleus and the cytoplasm is
tightlyregulatedineukaryoticcells.Nuclearimportprocessesinvolve
the nuclear pore complexes (NPCs) of the nuclear envelope and,
typically, require nuclear localization signals (NLSs). The nuclear
import of classical NLS-bearing proteins is mediated by specific
soluble factors, including Importin (Imp), which consists of two
subunits, Impa and Impb, small GTPase Ran/TC4, and nuclear
transport factor 2 [1]. The ternary complex with NLS-bearing
protein, Impa, and Impb translocates into the nucleus, and the
bindingGTP-boundformofRantoImpbtriggersthedissociation of
ternary complex, releasing Impa [2]. However, there are many
additional pathways that mediate nuclear import; for example,
Impb-like molecules (such as the transport factor for substrates
carrying the M9 shuttling signal or importin 7) and Impb itself are
competent to transfer some cargo by themselves [3]. In addition, it
was previously reported that Impa could migrate into the nucleus in
an Impb- and Ran-independent manner [4]. Impa alone can escort
Vpr,one of the accessoryproteins of humanimmunodeficiencyvirus
type 1 (HIV-1) [5,6], as well as Ca
2+/calmodulin-dependent protein
kinase type IV (CaMKIV) into the nucleus without utilizing the
classical Impb-dependent transport system [7].
Impa is composed of a flexible N-terminal Impb-binding (IBB)
domain and a highly structured domain comprising ten tandem
armadillo (ARM) repeats [2]. The helical ARM repeats assemble
into a twisted slug-like structure whose belly serves as the NLS-
binding groove. The central portion of Impa, which contains the
ARM repeats, recognizes the NLS cargo, while its N-terminal basic
region, termed the IBB domain, binds to Impb, and the region
between residues 383 and 497, corresponding to the ninth andtenth
ARM regions, binds to the cellular apoptosis susceptibility (CAS)
protein [2,8]. The crystal structure of Impa has shown that the
region between residues469and478,withinthe tenthARMregion,
contains the core sequences for CAS binding [8]. The nature of the
dissociation of the NLS cargo from Impa is unclear, but it has been
proposed that nucleoporins (Nups), together with CAS, assist in the
dissociationprocess[2,9].CASbindspreferentiallytoImpa,afterits
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cytoplasm. However, Impa has at least seven isoforms in human
[2,10,11], grouped into three subfamilies (a1, a2a n da3) based on
their amino acid sequence similarities. There is approximately 80–
90% sequence homology in each subfamily [2,12]. Subfamily a1
includes importin a5 (NPI-1/SPR1/karyopherin alpha 1
[KPNA1]), importin a6 (KPNA5) and importin a7 (KPNA6).
Subfamily a2 contains importin a1 (Rch1/SRP1a/KPNA2) and
the recently-reported importin a8 (KPNA7) [10,11]. Subfamily a3
includes importin a3 (Qip1/SRP3/KPNA4) and importin a4
(KPNA3). Members of the three subfamilies have about 50%
homology with each other [2,12]. Many studies have shown that
Impa isoforms differ in their efficiencies with respect to classical
substrate-specific import, show unique expression patterns in
various tissues and cells, and depend on the state of cellular
metabolism and differentiation [2,6,13]. Taken together, this
information suggests that Impa proteins contribute primarily to
tissue-specific nuclear transport.
Vpr has multiple biological functions, including nuclear localization
activity [14,15,16], arresting cells at the G2/M phase of the cell cycle
[17,18,19], increasing the activity of the HIV-1 long terminal repeat
[20], selective inhibition of cellular pre-mRNA splicing both in vivo and
in vitro [21,22], and positive and negative regulation of apoptosis [23].
These functions are carried out through interactions with a variety of
cellular partners. Especially, the virion-associated viral protein, Vpr, is
necessary for the nuclear import of the viral pre-integration complex
(PIC) in non-dividing cells [6,14,15,24], although its exact role in the
PIC entry mechanism remains unclear. There are several pathways
that Vpr could use to cross the nuclear envelope. First, numerous
investigations regarding the subcellular localization of Vpr suggest that
the Vpr protein may cross the nuclear envelope by passive diffusion, as
it is small enough (15 kDa) to pass through the NPC [15,25]. Second,
Vpr enters the nucleus by interacting with nucleoporins, which are
constituents of the NPC [26,27,28]. Third, Vpr binds to Impa ,w h i c h
stimulates subsequent nuclear import of the cargo by increasing the
affinity of Impa for NLS-containing proteins [16]. Another report
describes a novel nuclear import mechanism for Vpr, involving two
putative alpha-helical domains, located between residues 17 and 34
(aH1) and between residues 46 and 74 (aH3), which are required for
the nuclear localization of Vpr [25]. A subsequent study used
microinjection and in vitro transport assays incorporating the chimeric
protein VprN17C74 to show that the entire region between residues 17
and 74 is a bona fide NLS [5]. Furthermore, an in vitro transport assay
experiment designed to identify the factors required for VprN17C74
nuclear entry found that Vpr itself is targeted to the nuclear envelope
and is then transported by Impa, without any involvement of Impb
[5]. The three typical Impa isoforms, Rch1, Qip1 and NPI-1, appear
able to interact directly with VprN17C74 and support its nuclear entry.
Interestingly, the interaction between Impa and Vpr is necessary not
only for the nuclear import of Vpr but also for HIV-1 replication in
macrophages [6]. These results suggest that the interaction between
Vpr and Impa may be a potential target for therapeutic intervention.
Indeed, a potential parent compound, hematoxylin, has been
identified, which suppresses the VprN17C74-Impa interaction, thereby
inhibiting the nuclear import of the HIV-1 viral genome in
macrophages in a Vpr-dependent manner [29].
A nuclear magnetic resonance structural analysis revealed that full-
length Vpr forms three amphipathic alpha helices surrounding a
hydrophobic core [30,31]. It has a flexible, negatively-charged N-
terminal domain flanking the helices and its C-terminal domain is also
flexible, positively charged, and rich in arginine residues [30,31]. Two
m o t i f s ,a m i n oa c i d s5 6t o7 7i nt h et h i r da-helical domain (aH3) and
amino acids 77 to 96 in the arginine-rich C-terminal domain, are
critical for the inhibition of pre-mRNA splicing by Vpr [20], while the
C-terminal domain appears to be critical for Vpr-induced G2 arrest
and apoptosis [32,33]. The N-terminal domain was shown to be
important for localization to the nuclear rim [34]. Taken together,
these results clearly indicate that the N-terminal and the C-terminal
Vpr domains play critical roles in the multiple functions of Vpr.
However, it is unclear whether full-length Vpr enters the nucleus in a
manner similar to that of the chimeric protein, VprN17C74.I nt h i s
investigation, we have studied the detailed mechanism of full-length
Vpr entry into the nucleus. Using a digitonin-permeabilized transport
assay, the nuclear import of full-length Vpr by the three major
isoforms of Impa, Rch1, Qip1 and NPI-1, was analyzed. Further-
more, to clarify the means by which NPI-1 selectively transports full-
length Vpr, the Impa isoform domain involved in the interaction with
Vpr and these accurate binding affinities were identified using a
glutathione-S-transferase (GST)-pull down assay and surface plasmon
resonance (SPR). Moreover, we used a GST pull-down assay to show
that although Vpr binds to the CAS-binding domain of all of three
Impa isoforms to roughly the same extent, CAS can dissociate the
interaction between Vpr and NPI-1 but not between Vpr and Rch1 or
Q i p 1 .F i n a l l y ,w eu s e da nin vitro nuclear import assay using HeLa cells
with knocked-down CAS to demonstrate that CAS is required for the
nuclear entry of full-length Vpr.
Results
Full-length Vpr is preferentially imported into nuclei by
Impa5 (NPI-1)
A chimeric protein comprising full-length Vpr fused at the N-
terminus to GST and green fluorescent protein (GFP) (,63 kDa)
was constructed, which surpassed the limit for passive diffusion
into the nucleus (Fig. 1A). An in vitro nuclear import assay was
then performed using digitonin-permeabilized, semi-intact HeLa
cells (Fig. 1B). In the absence of soluble factors, full-length Vpr
localized predominantly to the perinuclear region in a manner
similar to that of the VprN17C74 mutant. By contrast, no signal was
detected in the perinuclear region when using a negative control
protein (a chimeric GST-GFP protein). Interestingly, the nuclear
import of Vpr changed significantly in the presence of the different
Impa isoforms. High levels of Vpr entered the nucleus in the
presence of NPI-1; however, the levels were much lower in the
presence of Qip1, and no entry was observed in the presence of
Rch1. By contrast, in agreement with a previous report [6], the
VprN17C74 mutant entered the nucleus at similar levels in the
presence of all three Impa isoforms. GST-GFP failed to enter the
nucleus, even in the presence of all three Impa isoforms.
Next, the extent of the nuclear import activity exhibited by Vpr
in the presence of 0.25, 0.5, 1 or 2 mM of the Impa isoforms was
examined by measuring the fluorescence intensity in the nucleus
(Fig. 1C). Only NPI-1 efficiently enhanced the nuclear import of
Vpr. Qip1 showed a very weak effect on the nuclear entry of Vpr,
which remained at a low level even in the presence of 2 mM Qip1.
By contrast, no nuclear import of Vpr was detected in the presence
of Rch1, even at a concentration of 2 mM.
The effect of Rch1 and Qip1 on the nuclear entry of full-length
Vpr mediated by NPI-1 was then examined (Fig. 1D). NPI-1–
mediated nuclear import of Vpr did not decrease in the presence
of Rch1 or Qip1. Moreover, the Impa isoform-driven nuclear
import of Vpr was completely inhibited when Impb was added to
semi-intact HeLa cells (Fig. 1E). Likewise, Impb decreased the
nuclear import of the VprN17C74 mutant in the presence of Rch1
(Fig. 1E). Taken together, these results suggest that full-length
Vpr is targeted to the perinuclear region and is then transported
into the nucleus by NPI-1 alone, without any requirement for
Impb.
CAS Regulates Nuclear Import of HIV-1 Vpr/NPI-1
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To examine further whether full-length Vpr interacts directly
with all three Impa isoforms, the recombinant GST-tagged Impa
isoforms, Rch1, Qip1 and NPI-1 (immobilized on glutathione-
Sepharose beads), were incubated with mRFP-Vpr purified from
vertebrate cells. Interestingly, full-length Vpr was able to interact
with all three isoforms (Fig. 1F), indicating that Vpr is able to bind
directly to Rch1 and Qip1, even though these isoforms did not
promote its nuclear entry as well as did NPI-1, which showed
preferential transport of Vpr into the nucleus.
Full-length Vpr binds to the Impa CAS-binding domain
Since the three major Impa isoforms, Rch1, Qip1 and NPI-1,
share approximately 50% overall amino acid sequence similarity
[2,12], we decided to determine whether the same domain was
involved in binding full-length Vpr in all three isoforms. Impa is
Figure 1. Importin a5/NPI-1 preferentially mediates the nuclear import of Vpr. (A) Twenty-five pmol of purified recombinant GST- and GFP-
tagged Vpr (Vpr), GST- and GFP- tagged VprN17C74 (N17C74), GST-tagged GFP (GST-GFP) were resolved by 10% SDS-PAGE and stained with Coomassie
brilliant blue (CBB). (B) Nuclear import of Vpr by importin a (Impa) isoforms. Digitonin-permeabilized HeLa cells were incubated with 1 mM of Vpr,
N17C74, and GST-GFP in the absence (-) or presence of 1 mM (for Vpr and GST-GFP) or 3 mM (for N17C74) of each of the recombinant Impa isoforms,
Rch1, Qip1 and NPI-1. Cells were fixed in 3.7% formaldehyde and stained with Hoechst 33342 to show the position of the nucleus (right panel). After
fixation, cells were analyzed by confocal laser scanning microscopy. Bar=10 mm. (C) Fluorescence intensity of Vpr per surface area was quantified for
at least 70 nuclei in the presence of the indicated concentrations of the Impa isoforms from three independent experiments. The bar shows the
standard errors of measurements. (D) In vitro nuclear import assay for GST-GFP-Vpr was performed in the absence (-) or presence of 1 mM of the Impa
isoforms. After fixation, cells were analyzed by confocal microscopy. Bar=10 mm. (E) In vitro nuclear import assay for Vpr was performed in the
absence (-) or presence of 1 mM of the Impa isoforms, and 1 mM of Impa isoforms with 1 mM Impb. N17C74, as a control, was performed with 1 mMo f
Rch1 and 1 mM Impb. After fixation, cells were analyzed by confocal microscopy. Bar=10 mm. (F) Binding assay between Vpr and the Impa isoforms.
Glutathione-Sepharose beads were coupled with the GST-Impa isoforms, Rch1, Qip1 and NPI-1 or GST alone, and were incubated with Vpr protein
purified from 293T cells transfected with pCAGGS mammalian vectors encoding Flag-mRFP (mRFP), or Flag-mRFP-Flag-Vpr (mRFP-Vpr). The bound
fractions and 1/20 of the input of mRFP-Vpr and mRFP were analyzed by immunoblotting with an anti-Flag M2 monoclonal antibody (MAb) (right
panel). Twenty-five pmol of GST or GST-Impa isoforms were resolved by 10% SDS-PAGE and stained with CBB (left panel). The positions of mRFP and
mRFP-Vpr are indicated.
doi:10.1371/journal.pone.0027815.g001
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domain comprised of ten tandem ARM repeats and a C-terminal
acidic domain [2], as shown in Fig. 2A. For each isoform, three
truncated mutants were prepared as fusion proteins with GST: 1)
the IBB domain mutant, 2) the mutant containing the ARM
repeat domain but lacking the tenth ARM repeat, and 3) the
mutant including the C-terminal region between the ninth ARM
repeat and the acidic domain, (Fig. 2B). These mutants were then
assessed for their binding activity with full-length Vpr (Fig. 2D).
The recombinant mutant corresponding to the ARM repeat
domain between residues 70 to 438 of Rch1 was very unstable and
was difficult to purify; therefore, a slightly extended form of the
mutant, between residues 70 to 475 but without the tenth ARM
repeat, was used.
Vpr bound to all mutants of all three Impa isoforms: two of the
deletion mutants, the ARM repeat domain lacking the tenth ARM
repeat (Rch170–475, Qip169–439 and NPI-176–451) and the C-
terminal region containing the ninth ARM repeat (Rch1404–529,
Qip1392–537 and NPI-176–541), bound to Vpr with the same level as
full-length Impa. The IBB domain mutant (Rch11–69, Qip11–68
and NPI-11–75) also interacted with Vpr, albeit with lower affinities
than those shown by the full-length Impa isoforms. These results
suggested that the main Vpr binding site is located somewhere
between the structural ARM repeats and the C-terminal region
but is not found in the IBB domain for all three Impa isoforms.
The two mutant forms that bound strongly to Vpr, as
mentioned above, shared the ninth ARM repeat (Fig. 2A).
Therefore, different truncated forms lacking the ninth ARM
repeat (Rch170–403, Qip169–391 and NPI-176–403) were constructed
(Fig. 2C) and a pull-down assay was performed using mRFP-Vpr
(Fig. 2E). The binding of the ARM repeat mutants lacking the
ninth ARM repeat to Vpr was reduced significantly, indicating
that the ninth ARM repeat region of all of three Impa isoforms
(Rch1404–475, Qip1392–439 and NPI-1404–451) is the major binding
site for full-length Vpr.
Full-length Vpr binds with similar affinity to the C-
terminal domain of the three Impa isoforms
To quantify the binding affinities between Vpr and each of the
Impa isoforms accurately, the BIAcore 2000 SPR sensor system
was used. In this system, four samples can be immobilized
individually on the same chip, and their interactions with analytes
can be tested simultaneously. Each of the three recombinant full-
length Impa isoforms and their C-terminal peptide mutants
(Rch1404–529, Qip1392–537 and NPI-176–541), the GST was cleaved
with PreScission protease, were immobilized on one lane of a
sensor chip and a remaining vacant lane was used as a negative
control for the non-specific binding of GST-Vpr and GST to the
chip. The chip-bound Impa isoforms were exposed to various
concentrations of GST-Vpr and GST, and their affinity constants
were measured by analyzing the curves (Fig. 3). Typical sensor
curves of various Vpr concentrations (0 to 40 mM) interacting with
full-length NPI-1 (NPI-1full) are shown in Fig. 3A. The binding
affinities obtained are summarized in Table 1. The KD values for
the full-length Vpr-Impa isoform interactions were very similar:
8.9 mM (Rch1), 6.8 mM (Qip1), and 7.4 mM (NPI-1). The KD
values for two of the Vpr-Impa C-terminal peptides were similar
to those for the full-length Impa isoforms, 6.5 mM (Qip1392–537)
and 6.7 mM (NPI-1404–541); however, the KD of the Rch1 C-
terminal peptide, 4.3 mM (Rch1404–529), showed a two-fold
decrease compared with the KD of full-length Rch1. This
experiment confirmed that the binding affinities between Vpr
and all Impa isoforms are very similar.
CAS disrupts the interaction between Vpr and NPI-1, but
not between Vpr an Rch1 or Qip1
The sequences required for binding to the CAS nuclear export
factor are located between the ninth and tenth ARM repeats
within Impa [2]. The present study indicated that the ninth ARM
repeat of Impa is the main region involved in binding to Vpr and
is also necessary for the interaction with CAS. Therefore, to
determine whether CAS affects the interaction between Vpr and
Impa, glutathione-sepharose beads coupled to GST-Rch1, -Qip1
or -NPI-1 were incubated with mRFP-Vpr in the absence or
presence of purified recombinant CAS and a RanGTP analog
(Q69LRanGTP) (Fig. 4A). RanGTP is necessary for the
interaction between Impa and CAS in cell nuclei. As shown in
Fig. 4B and C, the amount of Vpr bound to NPI-1 decreased as
the concentration of CAS increased in the presence of
Q69LRanGTP in a dose-dependent manner (a 0.2-fold difference
in the presence of 50 pmoles CAS). This was not the case for Rch1
and Qip1, indicating that CAS causes the dissociation of Vpr from
NPI-1 (which can import the full-length Vpr into the nucleus) but
does not disrupt Vpr/Rch1 or Vpr/Qip1 interactions, which are
not involved in Vpr nuclear import. When Q69LRanGTP was
absence on Pull-down assay, CAS only showed a very weak effect
on the dissociation of Vpr from NPI-1 (Fig. 4D).
CAS regulates the NPI-1–mediated nuclear entry of
full-length Vpr
Finally, the requirement for CAS for NPI-1–mediated nuclear
entry of full-length Vpr was confirmed using an in vitro nuclear
import assay. The results clearly showed that the expression of the
endogenous CAS protein was not affected by digitonin-induced
permeabilization (Fig. S1). Therefore, an in vitro nuclear import
assay was performed using HeLa cells in which CAS expression
had been knocked down. Knock-down was confirmed by
immunoblotting experiments conducted after a 36 h treatment
with two siRNAs (siRNA1 and siRNA2) against CAS mRNA
(Fig. 5A). HeLa cells were permeabilized with digitonin and used
in an in vitro import assay (Fig. 5B, C). The nuclear import of
GST-GFP-Vpr, which was enhanced by the addition of NPI-1,
was greatly decreased in HeLa cells treated with either CAS-
specific siRNA1 or siRNA2, but not in negative control siRNA-
transfected cells or in untreated cells. Furthermore, this reduction
in nuclear import was rescued by up to 50% by the addition of
exogenous CAS (recovery was considered to be 50% because
exogenous CAS needs time to reach the cell nuclei). However, Vpr
was able to localize to the nuclear envelope in these cells,
indicating that CAS has no effect on the perinuclear localization of
Vpr, an event that does not require both Impa isoforms. These
results clearly demonstrate that CAS is essential for the NPI-1–
mediated nuclear import of Vpr.
Discussion
This study investigated the nuclear import of full-length Vpr,
the HIV-1 accessory protein, using an in vitro nuclear import assay
with digitonin-permeabilized HeLa cells and a pull-down assay.
The results produced two major conclusions: first, the data
suggested that full-length Vpr is preferentially imported into the
nucleus by NPI-1 but not Rch1 and Qip1, in contrast with
VprN17C74, which can be imported by all three major isoforms of
Impa [6]. Certain previous studies have shown that each Impa
isoform imports different viral proteins; for example, Qip1
interacts with HIV-1 integrase (IN) and contributes to HIV-1
nuclear import and replication [35], while NPI-1 and Rch1
interact with the influenza virus Nucleoprotein to promote its
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import assay using HeLa cells with the knocked-down nuclear
export receptor, CAS, indicated that CAS is essential for the NPI-
1–mediated nuclear import of Vpr. We also showed that CAS
mediated the release of Vpr from NPI-1 but not from Rch1 and
Qip1, thus facilitating the transport of Vpr into the nucleus. It was
Figure 2. Mapping of the Impa isoform domains involved in the interaction with Vpr. (A) Schematic representation of the Impa isoforms,
Rch1, Qip1, NPI-1 and their deletion mutants. (B and C) All mutants were expressed as GST fusion proteins in E. coli and purified using Glutathione-
Sepharose. Twelve pmol of purified GST-tagged Impa isoform derivatives were resolved by 10% SDS-PAGE and stained with CBB. (D and E) Binding of
Impa isoforms to Vpr. Glutathione-Sepharose beads coupled to GST-Impa isoforms or GST alone were incubated with mRFP-Vpr or mRFP. The bound
fractions and 1/50 of the input of mRFP-Vpr and mRFP were analyzed by immunoblotting with anti-Flag M2 MAb (right panel). The positions of mRFP
and mRFP-Vpr are indicated.
doi:10.1371/journal.pone.0027815.g002
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of the NLS cargo/Impa/Impb complex, CAS increased the
dissociation of the Impa/NLS cargo complex together with
nucleoporins, such as Nup50, after the dissociation of Impb from
the ternary complex in the nucleus [2,37,38]. However, a
requirement for CAS in this process had not previously been
confirmed by in vitro nuclear import assay. In addition, it was
previously reported that although CaMKIV, which is transported
by Impa without utilizing Impb, binds to the C-terminal region of
mouse Rch1 (Rch1413–459) in a similar manner to Vpr, the
interaction between Impa and CaMKIV was not disrupted by the
addition of CAS in a solution-binding assay [7]. Therefore, this
study is the first to demonstrate, using in vitro nuclear import and
pull-down assays, that CAS is required for Impa-mediated nuclear
import and plays a direct role in the regulation of the NLS cargo-
Impa complex without utilizing the Impb-dependent transport
pathway.
Our present and previous results have allowed us to
characterize the mechanism governing the entry of full-length
Vpr into the nucleus as follows: i) full-length Vpr localizes to the
perinuclear region, without a requirement for soluble factors,
before it is transported into the nucleus by Impa, as shown by the
in vitro nuclear import assays using digitonin-permeabilized HeLa
cells (Fig. 1) and CAS-specific siRNA-treated permeabilized HeLa
cells (Fig. 5). This perinuclear localization in the absence of Impa
isoforms is in agreement with the nuclear import of VprN17C74
(Fig. 1B) [6] and distinguishes the nuclear import of Vpr from
that of other NLS-bearing proteins. ii) The detailed binding assay
with truncated forms of the three Impa isoforms showed that full-
length Vpr binds preferentially to the ninth ARM repeat, which is
also the domain required for CAS interaction with Impa. This
data partially agrees with a previous report in which VprN17C74
required the C-terminal peptide of Impa directly to entry into
nucleus, though it majorly bound to IBB domain of the Impa [5].
iii) Our SPR analysis clearly demonstrated similar binding
affinities for Vpr to each of the three full-length Impa isoforms
as well as to their C-terminal domains, which contained the ninth
ARM region, identified as the major Vpr-binding site, and also the
CAS binding site [8,37]. iv) This study demonstrated that the
release of Vpr from the Vpr/NPI-1 complex depends on CAS. By
contrast, CAS did not cause the dissociation of Vpr from
complexes with Rch1 or Qip1, even though they were capable
of importing Vpr into the nucleus (Fig. 4B, C). v) We also showed
that the nuclear import of Vpr by NPI-1 was not affected by Rch1
or Qip1 (Fig. 1D), suggesting that each of the Impa isoforms exist
in equilibrium with Vpr in the cytoplasm. It was assumed that all
the Impa isoforms have same binding affinity for Vpr (Fig. 3 and
Table 1). vi) After interacting with Impa at the perinuclear
region, full-length Vpr was selectively imported by NPI-1 but not
Figure 3. SPR measurements of the interaction between Vpr
and full-length or C-terminal Impa isoforms using BIAcore. (A)
SPR sensorgrams of the interactions between GST-Vpr and the full-
length Impa isoform, NPI-1full, immobilized to the CM sensor chip.
Sensor curves of the interactions between Vpr at various concentrations
(0 to 40 mM) and NPI-1full are shown. (B) The analysis curves used to
obtain the dissociation constants (KD) for the interactions between Vpr
and the Impa isoforms, Rch1full, Qip1full, NPI-1full, Rch1404-529, Qip1392-537
and NPI1404-541 using the steady state binding model equation (see
Material and Methods).
doi:10.1371/journal.pone.0027815.g003
Table 1. Dissociation equilibrium constants determined
using BIAcore.
Analite Ligand KD (M) Ligand KD (M)
Vpr Rch1full 8.9610
26 Rch1404–529 4.3610
26
Qip1full 6.8610
26 Qip1392–537 6.5610
26
NPI-1full 7.4610
26 NPI-1404–541 6.7610
26
Dissociation equilibrium constants determined using BIAcore. KD of Vpr was
determined by using the Vpr sensorgrams obtained by subtracting GST
sensorgrams from GST-Vpr sensorgrams at the same concentrations. Full: full-
length.
doi:10.1371/journal.pone.0027815.t001
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three isoforms of Impa (Fig. 1B) [6]. In addition, the NPI-1–
driven nuclear import of Vpr appeared to be completely inhibited
when Impb was added to the in vitro import assay as shown in
Fig. 1E. Thus, it seems that the transport of full-length Vpr is
mediated in an Impa-dependent/Impb-independent manner, as
was found previously for VprN17C74 [5,6]. vii) In an in vitro nuclear
import assay using HeLa cells with knocked-down CAS, we
showed that CAS promotes the NPI-1–mediated nuclear import of
Vpr. Taken together, the results suggested that the differences in
the dissociation rates for the interactions between Vpr and the
three Impa isoforms might permit the novel nuclear import of full-
length Vpr specifically mediated by NPI-1. Data from the present
study leads us to speculate that the Vpr N- or C-terminal region
will bind to the ninth ARM region of Impa with the potential
regulation of the nuclear import process through the dissociation
of Vpr from NPI-1 via an interaction with CAS. Indeed, it has
been reported that the C-terminal region of Vpr, which most
closely resembles a classical NLS, is highly involved in its nuclear
localization [39,40].
It is unclear how the selective release of full-length Vpr from
NPI-1 depends on CAS; however, there two possible hypotheses
with regards to its mechanism: first, it is predicted that since the
binding affinities of Vpr for the C-terminal domain were almost
the same for all three Impa isoforms, CAS must be attracted to
specific amino acids in NPI-1. Interestingly, the alignment of the
sequences of the ninth ARM motif, which are involved in the
binding of Vpr, showed that the three Impa isoforms share only
50% overall amino acid sequence similarity [2,11,12], suggesting
that the ARM motif of NPI-1 may be more effective at binding
CAS than that of Rch1 or Qip1. The second possibility relates to
the targeting of Vpr to the perinuclear region. Sun et al. [38]
showed that Impa/NLS cargo complexes, without Impb,
dissociated in the presence of CAS and RanGTP at the nuclear
pore complexes. They also speculated that Nup50 facilitates the
dissociation of Impa/NLS cargo complexes in the presence of
CAS and RanGTP when it reaches the nuclear basket region of
the NPC [38]. In a recent report, Ogawa et al. [9] speculated that
the dissociation of Impa from the NLS-substrate was promoted by
Npap60 (Nup50). In addition, interactions between transport
factors and key nucleoporins, such as Nup1p, Nup2p and Nup50,
appeared to accelerate the formation and dissociation of the NLS
cargo/Impa/Impb complexes [38]. Likewise, in this study, we
have also shown that the dissociation of the Vpr/NPI-1complexes
may occur at the perinuclear region using an in vitro nuclear import
assay with digitonin-permeabilized HeLa cells. In this assay, full-
length Vpr was targeted directly to the perinuclear region in the
absence of soluble factors, and, in addition, this perinuclear
localization increased in a dose-dependent manner upon the
addition of NPI-1. Earlier studies confirmed that Vpr can interact
with nuclear pore complex components [15,16,27,41] and we
have previously demonstrated that the interaction between Vpr
and the NPC is crucial for Vpr nuclear import, since Vpr mutants,
with barely detectable perinuclear localization, could not be
imported into the nucleus [5]. Further studies on the role of Vpr at
the NPC are now essential for a full understanding of the
mechanism of CAS-regulated, NPI-1–mediated nuclear import of
full-length Vpr.
Our results clearly indicate that the ninth ARM repeat region of
all of three Impa isoforms is the major binding site for full-length
Vpr. In contrast, we here demonstrate that the IBB domain of
Impa interacts with full-length Vpr, albeit with lower affinity than
Figure 4. CAS disrupts the interaction between Vpr and NPI-1. (A) Twenty-five pmol of purified recombinant RanQ69L and CAS were resolved
by 10% SDS-PAGE and stained with CBB. (B) Glutathione-Sepharose beads coupled with the GST-Impa isoforms, Rch1, Qip1 and NPI-1 (each 25 pmol)
or GST (25 pmol), were incubated with mRFP-Vpr, Q69LRanGTP (25 pmol) and/or CAS protein (5 and 50 pmol, respectively). The bound fractions of
mRFP-Vpr and mRFP were analyzed by immunoblotting with anti-Flag M2 MAb. (C) The immunoblots of mRFP-Vpr binding were analyzed by
densitometry and each sample was normalized to the Impa isoforms without CAS protein. Each column and error bar represents the means 6 SD of
results from three experiments. The asterisk* represents a p-value of ,0.0005. (D) Glutathione-Sepharose beads coupled with the NPI-1 (each
25 pmol) or GST (25 pmol), were incubated with mRFP-Vpr, Q69LRanGTP (25 pmol) and/or CAS protein (10 and 50 pmol, respectively). The bound
fractions of mRFP-Vpr were analyzed by immunoblotting with anti-Flag M2 MAb. The bound fractions and 1/20 of the input of mRFP-Vpr were
analyzed by immunoblotting with anti-Flag M2 MAb. The positions of mRFP-Vpr are indicated.
doi:10.1371/journal.pone.0027815.g004
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domains. This result partially corresponds to our previous finding
that Impa binds strongly to VprN17C74 via the IBB domain, but
this binding is not essential for the nuclear entry of Vpr [5]. The
IBB domain contains an NLS-like sequence (49-KRRNV-53) that
binds to autologous NLS-binding sites in a similar way to the NLS
of SV40. Thus, Impa appears to be prevented from binding to a
classical-type NLS by an internal NLS until Impb binds to the IBB
domain [42]. These facts suggest that Vpr might modulate the
interaction between a classical NLS-bearing protein and Impa,a s
does Impb. Interestingly, Bukrinsky and colleagues [16,43]
reported that Vpr associates with the N-terminal region of Impa,
which overlaps with the IBB domain of Impa and differs from the
classical NLS cargo binding site. This interaction may stimulate
nuclear import of the cargo by increasing the affinity of Impa for
NLS-containing proteins, including that of HIV-1 matrix (MA)
protein, which is one of the components of the PIC and has a basic
type of NLS. Thus, Vpr might accelerate nuclear import of the
PIC through interaction with the IBB domain, in addition to the
NPI-1-driven nuclear import of Vpr, that requires the C-terminal
domain of Impa.
Various factors are reported to adapt Impa isoforms for nuclear
import. Viral proteins, such as the herpes virus open reading frame
(ORF) 57 protein [44], the Influenza virus nucleoprotein [45,46],
and polymerase PB2 [47], appear to be transported by NPI-1.
Likewise, it was recently shown that HIV-1 IN appears to interact
with Qip1 and contributes to the nuclear import of PIC and viral
replication [35]. The results of the present study show that Vpr is
selectively imported into the nucleus by NPI-1, and previous work
shows that the interaction between Impa and Vpr is necessary not
only for the nuclear import of Vpr but also for HIV-1 replication
in macrophages [48]. Macrophages are a major target for HIV-1
and serve as a viral reservoir that releases small amounts of viral
particles in symptomatic carriers [49]. A striking feature of HIV-1
is its ability to replicate in non-dividing cells, particularly in
macrophages. Replication in non-dividing cells depends on the
active nuclear import of the viral PIC, which includes the viral
proteins, IN, Vpr, and small amounts of MA, in addition to viral
nucleic acids [48]. Vpr is particularly important for the nuclear
import of the PIC in non-dividing cells [6,14,15,24], although its
exact role in the PIC entry mechanism remains to be clarified.
Work is currently ongoing to study the expression of Impb in
human differentiated macrophages, and preliminary data suggest
that it is expressed at very low levels in primary differentiated
macrophages. The low level of Impb expression in macrophages
may result in the inefficient nuclear import of MA and IN, which
utilize the classical Impa/Impb-dependent nuclear import path-
way. By contrast, previous studies show that all three Impa
isoforms are strongly expressed at both the mRNA and protein
levels [6]. This suggests that, although Vpr utilizes many nuclear
import pathways [6,16,26,27,28], the Impa-mediated nuclear
import pathway is the most efficient in macrophages. In summary,
Figure 5. The siRNA-induced knock down of CAS prevents the nuclear import of Vpr. (A) CAS-specific siRNA and nonspecific siRNA
(negative control) transfections were performed in HeLa cells. After 36 h of treatment with CAS-specific siRNA1 and siRNA2 and the negative control
siRNA, cell extracts were prepared and immunoblotting with an anti-CAS antibody was used to determine the transfection efficiencies of the siRNAs.
Untreated HeLa cells (-). Actin was included as an internal control. The positions of CAS and actin are indicated. (B) Digitonin-permeabilized HeLa cells,
transfected with siRNAs, were incubated with 1 mM GST-GFP-Vpr, 1 mM NPI-1 and 1 mM CAS. After fixation, cells were analyzed by confocal laser
scanning microscopy. Bar=10 mm. (C) Fluorescence intensity per nuclear surface area was quantified in over 80 nuclei from three independent
experiments. The bar shows the standard errors of measurements.
doi:10.1371/journal.pone.0027815.g005
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mediates the release of Vpr from the Vpr-NPI-1 complex, thereby
allowing its transport into the nucleus. Further investigation of the
molecular mechanisms underlying the Vpr/NPI-1 interaction and
the selective release of full-length Vpr from NPI-1 and its
contribution to HIV-1 replication is required to facilitate a better
understanding of the HIV-1 nuclear import process.
Materials and Methods
Cell culture
Human cervical HeLa and 293T cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA)
supplemented with 10% heat-inactivated fetal bovine serum (FBS;
Sigma-Aldrich, St. Louis, MO) and GlutaMax (GIBCO Industries
Inc., Los Angeles, CA).
Plasmids
The following plasmids have been described previously: the
expression vector, pME18Neo, encoding Flag-tagged wild-type
Vpr and its control vector, pME18Neo; the expression vector,
pCAGGS, encoding Flag-mRFP-Flag-Vpr (mRFP-Vpr) and its
control vector, pCAGGS-Flag-mRFP (mRFP); and the GST
expression vector, pGEX-6P-3, encoding GST-tagged-Rch1, -
Qip1, -NPI-1 and -Impß [6,33,50,51]. The pCAGGS encoding
Flag-mRFP-VprN17C74 (mRFP-N17C74) was constructed as
described previously [50]. For the construction of the expression
vector pGEX-6P-3, encoding GST-tagged-Vpr (GST-Vpr), a
fragment encoding Vpr was amplified by PCR with the follow-
ing primers: 59-GGGGATCCGAACAAGCCCCAGAAGACC-
39 and 59-CCCTCGAGCTAGGATCTACTGGCTCC-39 from
pME18Neo-Flag tagged Vpr [33,51] and was subcloned into
pGEX-6P-3 (GE Health, Buckinghamshire, UK) at the BamHI/
XhoI sites. For construction of the expression vector, GST-green
fluorescent protein (GFP)-tagged Vpr (GST-GFP-Vpr), a cDNA
encoding histidine tag6 (His6)-tagged-Vpr (Vpr-His), was amplified
from pME18Neo-Flag tagged Vpr by PCR with the primers 59-
GGGATCCATGGAACAAGCCCCAGAAGA-39 and 59-GCG-
GCCGCTCAATGATGATGATGATGATGACCGGTCCCG-
GGGGATCTACT-39 and subcloned into the pGEX-6P-1-GFP
vector at the BamHI/NotI sites. The plasmid GST-VprN17C74-GFP
(GST-N17C74-GFP) has been described previously [5]. To
construct the expression vector, pGEX-6P-3-CAS, a cDNA
encoding CAS was prepared from pGEX-6P-2-GFP-CAS [9]
and ligated into pGEX-6P-3 at the BamHI/XhoI sites. To
construct the expression vector, pGEX-6P-3- Q69LRan, a cDNA
encoding wild-type Ran was cloned by PCR from a HeLa cDNA
library generated using SuperScript II (Invitrogen) according to
the manufacturer’s instructions. The N-terminal His-tag fused
Ran was then amplified by PCR and subcloned into pGEX-6P-3
(GE Healthcare Life Science). Q69LRan was generated using a
QuickChange II Site-Directed Mutagenesis kit (Stratagene)
according to the manufacturer’s instructions. For construction of
the truncated Impa isoform expression vectors, the fragments were
amplified by PCR and were subcloned into pGEX-6P-3 at the
BamHI/EcoRI sites for Rch1 and NPI-1 and the BamHI/XhoI sites
for Qip1. The following PCR primers were used: Rch1 1-69, 59-
CCCGGATCCTCCACCAACGAGAATGCTAATACACC-39
and 59-CCCGAATTCCTAGTTGCGGTTTTCCTGCAGC-
GG-39;7 0 –475, 59-CCCGGATCCAACCAGGGCACTGTAA-
ATTGG-39 and 59-GGGGAATTCCTAAGCTTCAATTT-
TGTCTAA -39; 70–402, 59-CCCGGATCCAACCAGGGCAC-
TGTAAATTGG-39 and 59-CCCGAATTCCTAGTTGGT-
CACGGCCCACACAGCTTCC-39; 403–529, 59-GGGGGATC-
CTATACCAGTGGTGGAACAG-39 and 59-GGGGAATTCC-
TAAAAGTTAAAGGTCCC-39; NPI-1 1–75, 59-CCCGGATC-
CACCACCCCAGGAAAAGAGAAC-39 and 59-GGGGAATT-
CCTACATGTTATTAATCTGAGCCTCATG-39; 76–405, 59-
CCCGGATCCGAGATGGCACCAGGTGGTGTC-39 and 59-
CCCGAATTCTCAGGCCCAAGCTGCTTCTTTTCTTG-39;
76–451, 59-CCCGGATCCGAGATGGCACCAGGTGGTGT-
C-39 and 59-GGGGAATTCTCACAGGATATTTTCCAAG-
CC-39; 406–538, 59-CCCGGATCCATCACAAATGCAACT-
TCTGG-39 and 59-GGGGAATTCTCAAAGCTGGAAACC-
TTCCATAG-39; Qip1 1–67, 59-CCCGGATCCGCGGACAAC-
GAGAAACT-39 and 59-GGGCTCGAGCTATCTATAAT-
CACCATCTATATCAGAG-39; 68–393, 59-CCCGGATCCGT-
GCAAAATACCTCTCTAGAA-39 and 59-GGGGCTCGAGC-
TAGGCCCAAGCAGCTTCTTTTTGAGTGC-39, 68–439, 59-
CCCGGATCCGTGCAAAATACCTCTCTAGAA-39 and 59-
GGGGCTCGAGCTACTAATATATTACTTAG-39; and 394–
521, 59-CCCGGATCCATAAGTAACTTAACAATTAGT-39
and 59-GGGCTCGAGCTAAAACTGGAACCCTTCTGTT-
GGTAC-39.
Protein expression and purification
The recombinant GST-tagged Rch1, Qip1, NPI-1, the deletion
mutants, GST-GFP, Impß and CAS were expressed in the
Escherichia coli strain BL21 CodonPlus (DE3)-RIL (Stratagene, La
Jolla, CA) and purified using the Glutathione Sepharose 4FF bead
system (GSH System, Amersham Biosciences, Piscataway, NJ) as
described elsewhere [6,50]. GST-Vpr and GST-GFP-Vpr were
purified as described elsewhere [52]. After expressing these
proteins in E. coli, cells were lyzed with Lysis Buffer [10 mM
Tris-HCl (pH 8.0), 500 mM NaCl, 1% Triton X-100, 5 mM 2-
Mercaptoethanol, 10% (w/v) glycerol and protein inhibitor].
GST-Vpr and GST-GFP-Vpr were purified using the GSH system
(Amersham Biosciences) and separated on a His-Trap column (GE
Health) [5,52]. GST-N17C74-GFP protein was purified as
described previously [5]. Purified GST-Vpr, GST-GFP-Vpr and
GST-N17C74-GFP proteins were dialyzed against transport
buffer [TB: 20 mM HEPES-KOH [pH 7.3], 110 mM potassium
acetate, 2 mM magnesium acetate, 5 mM sodium acetate and
1 mM dithiothreitol (DTT)]. RanQ69L was expressed from
pGEX-6P-3 and purified on GSTrap and HisTrap column (GE
Healthcare), and after nucleotide exchange for GTP, GST was
digested by PreScission Protease and separated on Hi-Trap SP
column (GE Healthcare). Activity was confirmed by binding with
GST-Importin b.
To express and purify the Flag fusion proteins, 293T cells
(5610
5 cells) were transfected with 5 mg of the pCAGGS
mammlaian expression vector encoding mRFP-Vpr, mRFP-
N17C74 or mRFP using FuGene HD Transfection Reagent
(Roche Diagnostics, Basel, Switzerland). Two days after transfec-
tion, expressed proteins were purified using ANTI-FLAG M2
agarose (Sigma-Aldrich) as described previously [50].
In vitro nuclear import assay
HeLa cells (2610
6) were seeded on an eight-well coverslip in a
10-cm dish. After 16 to 24 h of culture, HeLa cells were
permeabilized by digitonin in TB on ice for 5 min and washed
twice with TB as described previously [25]. The permeabilized
cells were incubated at room temperature for 1 h or 30 min with
1% bovine serum albumin, GST-GFP-Vpr (for 1 h), GFP-GST
(for 1 h) or GST-N17C74-GFP (for 30 min), and transport
substrates in a total volume of 10 ml per sample. After incubation,
the cells were washed twice with TB and fixed in 3.7%
formaldehyde in TB. Samples were examined using confocal laser
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nuclear fluorescence intensity was analyzed with MetaMorph
software (Molecular Devices Inc., Downingtown, PA). For each
condition, the fluorescence intensity per nuclear surface area was
quantified for at least 70 nuclei stained with Hoechst 33342
(ImmunoChemistry Technologies LLC., Bloomington, MN).
Pull-down assay
Glutathione-Sepharose 4FF beads were coupled with GST-Impa
isoforms and their mutants in TB for 1 h at 4
oC and then in 10 mM
Tris-HCl (pH 8.0), 50 mM NaCl, 0.05% NP-40 and 1 mM DTT.
Vpr proteins purified from 293T cells transfected with pCAGGS
encoding mRFP or mRFP-Vpr were incubated with GST-protein
conjugated beads for 2 h at 4
oC. The beads were washed four times
with 500 ml washing buffer [10 mM Tris-HCl (pH 8.0), 150 mM
NaCl, 0.2% NP-40 and 1 mM DTT] and bound proteins were
eluted by incubation with sodium lauryl sulfate (SDS) sample buffer
[100 mM sodium phosphate (pH 7.2), 1% SDS, 10% glycerol,
100 mM DTT and 0.001% bromophenol blue] at 98uC for 5 min.
Eluted proteins were fractionated by 10% SDS-polyacrylamide gel
electrophoresis (PAGE) and detected by Western blotting with anti-
Flag M2 monoclonal antibody (MAb) (Sigma-Aldrich).
Immunoblotting
Cells or proteins were dissolved in SDS sample buffer, heat-
denatured and loaded onto 10% SDS polyacrylamide gels.
Separated proteins were transferred to a polyvinylidene difluoride
membrane (Immobilon; Millipore, Bedford, MA). After treatment
with PBST [20 mM Dulbecco’s phosphate-buffered saline (PBS)
and 0.05% (v/v) Tween 20] containing 5% skim milk at room
temperature for 1 h, the blotted membrane was incubated with
anti-Flag MAb (M2) (Sigma-Aldrich), anti-CAS polyclonal antibody
(CSE1L, Medical & Biological Laboratories Co. Ltd., Nagoya,
Japan), oranti-actinpolyclonalantibody(SantaCruz Biotechnology
Inc., Santa Cruz, CA) diluted with PBST containing 3% skim milk
at room temperature for 2 h or at 4
oC for 16 to 18 h. The
membrane was rinsed with PBST and incubated with horseradish-
peroxidase (HRP)-conjugated goat anti-mouse IgG (Zymed Labo-
ratories, San Francisco, CA) for anti-Flag, HRP-goat anti-rabbit
IgGs (Zymed Laboratories) for anti-CAS, or HRP-rabbit anti-goat
IgG (Zymed Laboratories) for anti-actin. Each antibody was diluted
with PBST containing 3% skim milk. After washing with PBST, the
bound antibodies were visualized with ECL
TM Blotting Detection
Reagents (Amersham Biosciences) followed by exposure to X-ray
film (Kodak BioMax
TM XAR film, Sigma-Aldrich).
Surface plasmon resonance (SPR) analysis
SPR experiments were performed using the BIAcore 2000
system (GE Health) at room temperature. Impa isoforms and their
mutants were coupled directly to the sensor chip (CM5 research
grade, GE Health) via standard N-hydroxysuccinimide and N-
ethyl-N-(dimethylaminopropyl) carbodiimide activation. To im-
mobilize the proteins, full-length Rch1 [dissolved in 10 mM
sodium acetate buffer (pH 5.0)] full-length Qip1 and full-length
NPI-1 [dissolved in 10 mM sodium acetate buffer (pH 4.5)], and
their mutants [dissolved in 10 mM sodium acetate buffer (pH 4.0)]
were injected onto the sensor surface with HBS EP buffer [10 mM
Hepes (pH 7.4), 150 mM NaCl, 3 mM ethylenediaminetetraacetic
acid, and 0.05% surfactant P20; GE Healthcare] employed as the
mobile phase buffer during the immobilization process. Following
immobilization, 50 mM Tris-HCl buffer (pH 7.5) was injected to
quench the unreacted N-hydroxysuccinimide groups, and then
PBS was used as the mobile phase buffer. GST and GST-Vpr
samples at various concentrations were injected as analytes, and
bound analytes were subsequently removed by washing with the
mobile phase buffer at 300 s after the injection. Vpr sensorgrams
were obtained by subtracting GST curves from GST-Vpr curves.
Kinetic constants were calculated from the Vpr sensorgrams using
the BIA evaluation software, version 3.0 Biacore AB (GE
Healthcare). Dissociation constants (KD) were calculated from
the resonance unit at equilibrium using the following equation:
Req~
Req:C
CzKD
where Req is the steady state binding level, KD is the dissociation
constant and C is the analyte concentration. Req is related to
concentration according to this equation.
Small interfering RNAs (siRNA)
The siRNAs against CAS were designed with the BLOCK-iT
RNAi Designer (Invitrogen). The siRNA forward sequences
targeting CAS were 59-AGCAACAGUGGAUAAUUCU-
GAUUUC-39 for siRNA1 and 59-UUAACUGCUUCUGAAU-
UUGCUCUGG-39 for siRNA2. HeLa cells (1610
6) were seeded
on a 6-cm dish. After cells had adhered to the dish, the cells were
transfected with the siRNAs using Lipofectamine RNAiMAX
(Invitrogen) according to the manufacturer’s protocols. After 16 h,
cells (2610
6) were seeded onto an eight-well coverslip within a 10-
cm dish and were used in an in vitro import assay following 36 h
incubation with an siRNA.
Statistical methodology
Statistical analyses were conducted using R version 2.8 (1).
Supporting Information
Figure S1 Immunofluorescent staining of endogenous
CAS in semi-intact cells. The two panels show the steps
involved in cell preparation for the in vitro import assay: intact cells
(left panel), digitonin-treated cells and the cells incubated on ice for
5 min following digitonin treatment (right panel). Cells on cover
slips were fixed with 3.7% formaldehyde in PBS for 15 min at room
temperature and permeabilized with PBS containing 0.5% Triton
X-100 for 7 min on ice. The cells on the coverslips were incubated
with either anti-CAS polyclonal antibody (Green) or anti-Rch1
MAb (Red) in PBS containing 5% skim milk for 1 h at RT. After
rinsing with PBS, the cells were incubated with either Alexa-488–
conjugated anti-rabbit IgG (for CAS) or Alexa-546–conjugated
anti-mouse IgG (for Rch1) antibodies (Invitrogen), or Hoechst
33342 (ImmunoChemistry Technologies LLC.) in PBS containing
5% skim milk for 30 min. After rinsing with PBS, the cover slips
weremounted on glass slides in PBS containing90%glycerolbefore
analysis by confocal laser scanning microscopy. Bar=10 mm.
(TIF)
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